Robert Reid

Dr. Robert Reid is a Senior Postdoctoral Fellow at the Institute for Molecular Bioscience, University of Queensland. His research focuses on epigenetic regulation, immunology, and drug discovery, particularly targeting histone deacetylases (HDACs), complement proteins, and protease inhibitors. He has contributed to understanding HDAC7's role in immunometabolic pathways and macrophage function, with recent work emphasizing anti-inflammatory agents and antiparasitic drug development.

Key research areas include the interplay between HDAC enzymes and cellular metabolism, bacterial virulence mechanisms, and the design of small-molecule inhibitors. His publications span over two decades, with notable contributions to malaria drug discovery and the structural biology of HIV protease inhibitors. Dr. Reid collaborates extensively with teams exploring macrophage biology, bacterial pathogenesis, and translational drug development.

His work has advanced the understanding of how HDAC inhibitors modulate immune responses and metabolic pathways, with potential applications in treating inflammatory diseases, cancer, and infectious diseases. He holds patents related to HDAC inhibitors and complement receptor antagonists, reflecting his focus on translational research.